NCT03965390

Brief Summary

The effect of periodontal disease on the general condition of patients remains today underestimated in Parkinson's disease. The BUCCO-PARK project aims to carry out an exploratory study of oral therapeutic education on the clinical evolution and fate of the microbiota of patients undergoing brain stimulation surgery. During the study, patients will follow the standard care pathway alone or combined with an oral therapeutic education. Biological samples will assess how the microbiota of these patients will be impacted. BUCCO-PARK aims to optimize the care of Parkinson's patients by integrating oral care.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
15

participants targeted

Target at below P25 for not_applicable parkinson-disease

Timeline
Completed

Started Dec 2019

Longer than P75 for not_applicable parkinson-disease

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 21, 2019

Completed
8 days until next milestone

First Posted

Study publicly available on registry

May 29, 2019

Completed
7 months until next milestone

Study Start

First participant enrolled

December 14, 2019

Completed
3.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 19, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 19, 2023

Completed
Last Updated

June 6, 2024

Status Verified

June 1, 2024

Enrollment Period

3.4 years

First QC Date

May 21, 2019

Last Update Submit

June 4, 2024

Conditions

Keywords

oral microbiotaparkinsonbrain stimulation surgeryoral therapeutic

Outcome Measures

Primary Outcomes (1)

  • Parodontal disease progression after 12 months

    Parodontal disease progression according to criteria defined by CDC/AAP 6 months after surgery

    12 months

Secondary Outcomes (21)

  • Parodontal disease progression after 6 months

    6 months

  • Parodontal disease progression at inclusion

    1 month

  • Caries index progression

    12 months

  • Plaque index progression

    12 months

  • Gingival index progression

    12 months

  • +16 more secondary outcomes

Study Arms (2)

Classical care pathway

NO INTERVENTION

Patients are following classical care pathway. Before brain surgery patients will be included after oral, medical and life quality evaluation. After randomization in the control group, patients will be evaluated at 6 and 12months after surgery, during classical follow up visits.

Oral education

EXPERIMENTAL

Patients are following classical care pathway but combined at each visit with an oral education Before brain surgery patients will be included after oral, medical and life quality evaluation. After randomization in the experimental group, patients will be evaluated at 6 and 12 months after surgery, during classical follow up visits. At each timepoint an oral education will be realized in parallel.

Behavioral: Oral education

Interventions

Oral educationBEHAVIORAL

Oral therapeutic education aims to improve dietary practices, daily hygiene and care, in an approach adapted to the characteristics and consequences of Parkinson's disease. An oral prevention package will be given to patients. Initially, dentists expose various oral health problems commonly found in Parkinson's disease, in order to give patients the necessary information for the understanding Secondly, dentists dispenseront practical advice tailored to pathology, to maintain good oral health

Oral education

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with idiopathic Parkinson's disease for whom deep brain stimulation surgery (indifferent target) has been indicated for their Parkinson's disease
  • affiliated to a system of social security;
  • having at least 10 natural teeth (treated or not)
  • having received oral and written information on the protocol and having signed a consent to participate in this research.

You may not qualify if:

  • pregnant or lactating women;
  • Persons of legal age subject to legal protection (safeguard of justice, guardianship, tutorship), persons deprived of their liberty;
  • Patients who do not speak French (both written and spoken);
  • Patients whose oral status is considered incompatible by the dental surgeon investigator with entry into the study (history of major maxillofacial surgery, presence of drugs that may cause gingival hypertrophy 2 or gingival bleeding 3).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU de Rennes

Rennes, 35033, France

Location

MeSH Terms

Conditions

Parkinson Disease

Interventions

Educational Status

Condition Hierarchy (Ancestors)

Parkinsonian DisordersBasal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesMovement DisordersSynucleinopathiesNeurodegenerative Diseases

Intervention Hierarchy (Ancestors)

Socioeconomic FactorsPopulation Characteristics

Study Officials

  • Marc VERIN, Pr

    Rennes University Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 21, 2019

First Posted

May 29, 2019

Study Start

December 14, 2019

Primary Completion

May 19, 2023

Study Completion

May 19, 2023

Last Updated

June 6, 2024

Record last verified: 2024-06

Locations